U.S. Retail REITs Stock News

NasdaqGS:ICFI
NasdaqGS:ICFIProfessional Services

A Look At ICF International (ICFI) Valuation As Earnings And Revenue Pressure Return

ICF International (ICFI) is in focus ahead of tomorrow’s quarterly earnings release, with analysts expecting an 8% year on year revenue decline after several quarters of missed revenue estimates. See our latest analysis for ICF International. ICF International’s share price has been volatile, with a 7.31% 7 day share price return and an 8.77% 30 day share price return, in contrast to a 16.71% 90 day share price decline and a 12.19% 1 year total shareholder return decline. This suggests...
NYSE:WKC
NYSE:WKCOil and Gas

World Kinect (WKC) Valuation After First Quarter Return To Profitability

World Kinect (WKC) returned to profitability in the first quarter of 2026, reporting US$9,685 million in sales and US$26.2 million in net income, alongside earnings per share turning positive from continuing operations. See our latest analysis for World Kinect. Despite the return to profitability, the stock has had mixed momentum, with a 1 day share price return of a 2.97% decline but a 30 day share price return of 15.41%, while the 3 year total shareholder return of 24.44% contrasts with a 5...
NYSE:PBI
NYSE:PBICommercial Services

Pitney Bowes (PBI) Q1 EPS Jump To US$0.40 Tests Revenue Skeptic Narratives

Pitney Bowes (PBI) has opened 2026 with Q1 revenue of US$477.4 million and basic EPS of US$0.40, while its trailing twelve month figures stand at US$1.9 billion in revenue and basic EPS of about US$1.04, setting a clear baseline for how the business is currently performing. Over recent quarters, the company has seen revenue move from US$493.4 million in Q1 2025 to US$477.4 million in Q1 2026, with basic EPS shifting from roughly US$0.19 to US$0.40. Investors are likely to focus on how these...
NYSE:SPG
NYSE:SPGRetail REITs

A Look At Simon Property Group (SPG) Valuation As Analysts Lift Earnings And Occupancy Expectations

Recent revisions to Wall Street forecasts have put Simon Property Group (SPG) back in focus, as analysts now expect higher EPS, stronger revenue and firmer U.S. mall occupancy in the upcoming earnings report. See our latest analysis for Simon Property Group. SPG’s recent momentum has been positive, with a 1 day share price return of 1.58%, a 30 day share price return of 8.03%, and a 1 year total shareholder return of 33.61%. This suggests that sentiment has improved alongside the higher...
NYSE:AXS
NYSE:AXSInsurance

A Look At AXIS Capital Holdings (AXS) Valuation After Strong Q1 Results And Renewed Buy Rating

AXIS Capital Holdings (AXS) entered the spotlight after reporting first quarter earnings, with revenue of US$1,643.63 million and net income of US$254.77 million, along with higher earnings per share compared with a year earlier. See our latest analysis for AXIS Capital Holdings. AXIS Capital Holdings’ share price, recently at US$99.37, has a year to date share price return decline of 4.69% and a 1 year total shareholder return of 1.07%, alongside a 3 year total shareholder return of 93.69%...
NYSE:JOBY
NYSE:JOBYAirlines

Joby Aviation (JOBY) Q1 Loss Of US$110 Million Tests Bullish Growth Narratives

Joby Aviation (JOBY) opened 2026 with Q1 revenue of US$24.2 million, a basic EPS loss of US$0.12, and a net income loss of US$110.0 million. This provides a clear snapshot of where the business currently stands on growth versus profitability. The company’s quarterly revenue moved from US$0.0 million in Q1 2025 to US$24.2 million in Q1 2026, while quarterly basic EPS over the same period ranged from a loss of US$0.11 to a loss of US$0.48. This leaves investors focused on how quickly margins...
NasdaqGM:ORKA
NasdaqGM:ORKABiotechs

Psoriasis Data, Halozyme Pact and Equity Raise Might Change The Case For Investing In Oruka Therapeutics (ORKA)

In late April 2026, Oruka Therapeutics reported positive interim Phase 2a data for its psoriasis drug candidate ORKA-001 and secured a US$700.35 million follow-on equity offering alongside a global exclusive collaboration and license agreement with Halozyme Therapeutics to apply Hypercon™ delivery technology to ORKA-001. Together, the strong clinical efficacy signals, sizable capital raise, and Halozyme partnership position ORKA-001 as a potentially more convenient biologic option in...
NasdaqCM:OSS
NasdaqCM:OSSTech

A Look At One Stop Systems (OSS) Valuation After Q1 2026 Beat And Upbeat 2026 Guidance

One Stop Systems (OSS) is back in focus after its Q1 2026 earnings topped expectations, with revenue of US$8.07 million and non GAAP profitability, alongside upbeat guidance that has sharpened market attention on the stock. See our latest analysis for One Stop Systems. The Q1 2026 beat and fresh acquisition plans arrived alongside sharp share price momentum, with a 1 day share price return of 56.91% and year to date share price return of 125.44%. The 1 year total shareholder return is very...
NasdaqGS:QCOM
NasdaqGS:QCOMSemiconductor

Is It Too Late To Consider Qualcomm (QCOM) After Its Recent 55% Monthly Surge?

If you are wondering whether QUALCOMM's current share price fairly reflects its prospects, this article walks through the key numbers so you can judge the stock's value with more confidence. QUALCOMM's stock, which last closed at US$192.57, has posted returns of 7.2% over 7 days, 55.2% over 30 days, 11.3% year to date, 35.8% over 1 year, 98.2% over 3 years, and 69.0% over 5 years. Recent price moves sit against a backdrop of ongoing attention on Qualcomm's role in semiconductors and wireless...
NYSE:ORCL
NYSE:ORCLSoftware

Oracle’s AI Push And Valuation Case Center On New Mega Contracts

Oracle (NYSE:ORCL) secured US$16b in financing for a Michigan AI data center that will support OpenAI applications, resolving local opposition that had threatened the project. The company agreed terms with township authorities that clear a path for large scale build out of the facility. Oracle was awarded a classified AI contract with the U.S. Department of Defense for secure workloads. The company was also recognized as a Leader in the Gartner Magic Quadrant for Warehouse Management for the...
NasdaqGS:CSCO
NasdaqGS:CSCOCommunications

Should Cisco’s Astrix Deal and Quantum Push Reshape the AI Security Narrative for Cisco Systems (CSCO) Investors?

Cisco Systems recently announced its intention to acquire Israeli cybersecurity firm Astrix Security, an AI-focused non-human identity protection specialist, in a deal reportedly around US$300 million, while also unveiling the Cisco Universal Quantum Switch, a room-temperature device designed to route and translate quantum information across multiple encoding formats on standard telecom fiber. Together, these moves highlight Cisco’s push to secure AI agents and advance full-stack quantum...
NYSE:SPOT
NYSE:SPOTEntertainment

How Spotify’s Peloton Partnership and Capital Moves Could Reshape Spotify Technology (SPOT) Investors’ Expectations

In late April 2026, Spotify Technology reported first-quarter revenue of €4,533 million with net income of €721 million, issued second-quarter 2026 guidance calling for approximately €4.8 billion in revenue and a 33.1% gross margin, and confirmed completion of a US$904.11 million share repurchase program alongside a new US$138.83 million ESOP-related shelf registration. At the same time, Peloton announced a global partnership that brings more than 1,400 of its fitness and wellness classes...
NasdaqGS:PZZA
NasdaqGS:PZZAHospitality

Is It Time To Reconsider Papa Johns (PZZA) After Its Recent Share Price Weakness

If you are wondering whether Papa John's International at around US$33.78 still offers value or is a value trap, the key is to look past the headline share price and into how the market is currently pricing the business. The stock has seen a 3.6% decline over the last 7 days, a 4.1% decline over 30 days and is down 16.2% year to date, while the 1 year return stands at 6.2%. The 3 and 5 year returns are 51.8% and 59.3% declines respectively, which can change how investors think about both...
NYSE:BCO
NYSE:BCOCommercial Services

Brink's (BCO) Q1 EPS Drop To US$0.78 Tests Bullish Earnings Growth Narrative

Brink's (BCO) opened 2026 with Q1 revenue of US$1.4 billion and basic EPS of US$0.78, setting the tone for how investors gauge the latest move in profitability. Over recent quarters, revenue increased from US$1.25 billion in Q1 2025 to US$1.38 billion in Q4 2025 and to US$1.4 billion in Q1 2026. Over the same period, basic EPS moved from US$1.20 to US$1.64 and then to US$0.78, with trailing twelve month EPS at US$4.33. With trailing net margins in the low single digits and interest coverage...
NYSE:FINV
NYSE:FINVConsumer Finance

FinVolution Group (FINV) Valuation Check After FY25 Results And Rating Upgrade To Cautious Buy

FY25 results bring mixed signals for FinVolution Group (FINV) FinVolution Group (FINV) recently reported FY25 results that showed revenue and operating income declines linked to regulatory and credit headwinds, while its international business delivered 25% of revenue and a US$15 million profit. See our latest analysis for FinVolution Group. The stock has reacted in a mixed way to these updates, with a 7-day share price return of 7.63% and a weaker 1-year total shareholder return of 33.87%...
NYSE:EPRT
NYSE:EPRTREITs

A Look At Essential Properties Realty Trust (EPRT) Valuation As Recent Analysis Highlights Resilient Growth Drivers

Why recent analysis on Essential Properties Realty Trust (EPRT) is getting attention Fresh analysis highlighting Essential Properties Realty Trust (EPRT) focuses on its high occupancy, conservative balance sheet, and exposure to undersupplied small box retail, all under macro conditions that may influence inflation and interest rates. See our latest analysis for Essential Properties Realty Trust. At a latest share price of $31.40, Essential Properties Realty Trust has had a 4.46% year to date...
NasdaqGS:KLIC
NasdaqGS:KLICSemiconductor

Kulicke and Soffa Industries (KLIC) Is Up 12.0% After Sharp Earnings Turnaround - Has The Bull Case Changed?

Kulicke and Soffa Industries recently reported past second-quarter 2026 results, with sales rising to US$242.62 million and net income improving to US$35.15 million, compared with a net loss a year earlier. Over the first six months of fiscal 2026, the shift from a small loss to more than US$51.94 million in profit underscores a sharp operational turnaround and stronger earnings power. With this earnings rebound and higher sales as a backdrop, we’ll now examine how the results may reshape...
NasdaqGS:NWBI
NasdaqGS:NWBIBanks

Should Northwest Bancshares' (NWBI) Strong Q1, Dividend, and New Buyback Shift Investor Expectations?

In late April 2026, Northwest Bancshares, Inc. reported first‑quarter results showing higher net interest income of US$142.48 million and net income of US$50.54 million year over year, alongside board approval of a US$0.20 quarterly dividend and a new US$50 million share repurchase program. The continuation of 126 consecutive quarterly cash dividends, combined with buyback authorization and solid loan‑driven earnings, highlights management’s emphasis on consistent capital returns while...
NasdaqGS:NWPX
NasdaqGS:NWPXConstruction

A Look At NWPX Infrastructure (NWPX) Valuation After Its Recent Sharp Share Price Move

Event driven move in NWPX Infrastructure NWPX Infrastructure (NWPX) has quietly drawn attention after a sharp share price move over the past week and month, prompting investors to recheck what the water focused infrastructure stock is currently pricing in. See our latest analysis for NWPX Infrastructure. That sudden move sits on top of already strong momentum, with a 30 day share price return of 41.78% and a year to date gain of 76.42%, alongside a 1 year total shareholder return of 198.68%...
NasdaqCM:VKTX
NasdaqCM:VKTXBiotechs

Should Viking’s VK2735 Obesity Data Debut in Europe Require Action From Viking Therapeutics (VKTX) Investors?

Viking Therapeutics, Inc. has announced it will present two posters on its VK2735 obesity program at the 33rd European Congress on Obesity in Istanbul on May 12–15, 2026, including Phase 2 VENTURE-Oral efficacy and safety data and Phase 3 VANQUISH-1 trial design details. This upcoming disclosure of oral and subcutaneous VK2735 data highlights Viking’s push to compete with existing GLP-1 and dual GLP-1/GIP obesity treatments such as semaglutide and tirzepatide. We’ll now examine how the...
NYSE:S
NYSE:SSoftware

A Look At SentinelOne (S) Valuation After Launch Of Wayfinder Frontier AI Services

SentinelOne (S) has put AI-driven exposure management at the center of its story, launching Wayfinder Frontier AI Services alongside deeper collaborations with Anthropic, Google Cloud, and Silverfort to address real world exploitability across modern attack surfaces. See our latest analysis for SentinelOne. The rollout of Wayfinder Frontier AI Services comes after a strong run in the stock, with a 30 day share price return of 13.47% and a 90 day share price return of 18.56%. This is occurring...
NasdaqCM:OSS
NasdaqCM:OSSTech

One Stop Systems (OSS) Is Up 61.5% After Narrowing Losses And Highlighting M&A Firepower - Has The Bull Case Changed?

In early May 2026, One Stop Systems, Inc. reported first-quarter 2026 results showing revenue of US$8.07 million versus US$5.21 million a year earlier, with net loss narrowing to US$519,862 from US$2.02 million. Management also highlighted that a stronger balance sheet now gives the company room to invest in its own operations and pursue selective acquisitions to broaden its technology platform and customer reach. Now we'll examine how this combination of higher revenue with a smaller loss...
NasdaqGM:IOVA
NasdaqGM:IOVABiotechs

Is Iovance Biotherapeutics’ (IOVA) Stock Authorization Request Quietly Rewriting Its Financing Playbook?

Iovance Biotherapeutics recently saw short interest in its shares fall and institutional investors increase their positions ahead of the company’s upcoming Q1 2026 earnings report. At the same time, Iovance has asked shareholders to approve an increase in authorized common stock to 650,000,000 shares, signaling preparation for potential future financing or corporate initiatives. With institutional buying and reduced short interest pointing to shifting sentiment, we’ll examine how this news...
NYSE:MOD
NYSE:MODBuilding

Is Modine (MOD) Quietly Redefining Its Edge With Data Center Cooling And A Portfolio Shakeup?

On May 5, 2026, Modine Manufacturing Company’s CEO Neil D. Brinker and CFO Michael B. Lucareli held a virtual fireside chat at the Oppenheimer 21st Annual Industrial Growth Conference, with a webcast replay available on the company’s investor relations site for a full year. This appearance comes as Modine gains attention for reshaping its portfolio around data center cooling, sustainability initiatives, and a pending Performance Technologies spin-off supported by an amended credit...